The National Academy of Medicine (NAM) and the New England Journal of Medicine (NEJM) have partnered to launch a new series designed to bring evidence-based policy insights to the NEJM readership. The From the National Academy of Medicine series will distill findings and recommendations from reports of the NAM and the National Academies of Sciences, Engineering, and Medicine to inform scientific and clinical practice as well as public policies that impact health.
The series was launched on July 31, 2024, with an editorial co-authored by NEJM editor-in-chief Eric Rubin and NAM president Victor J. Dzau. “To understand how science can best be turned into health policy, leaders and policymakers including the U.S. administration and Congress have long turned to the National Academy of Medicine (NAM) and its fellow National Academies,” Rubin and Dzau write in the editorial. “The Academies approach difficult questions by recruiting key academic, industry, and government experts to provide balanced and unbiased advice and organize reports on a range of national and international issues. Today the NAM and the Journal are proud to … bring the key information in many of these reports to a broad readership.”
The first article in the series, “Long Covid Defined” (co-authored by E. Wesley Ely, Lisa Brown, and Harvey Fineberg) details key findings from the June 2024 National Academies report Long-Term Health Effects of COVID-19: Disability and Function Following SARS-CoV-2 Infection. “This report offers a comprehensive review of the evidence base for how Long COVID may impact a patient’s ability to engage in normal activities, such as going to work, attending school, or taking care of their families,” said Dzau in a press release. “Its findings will be useful to anyone attempting to understand how Long COVID may affect the millions of people in the U.S. who have reported symptoms.”
Resources
